Exelixis | Leverandørgæld



Trade Creditors Lave om Dato
Acadia Pharmaceuticals USD 16.19M 2.89M 2024-12
Agios Pharmaceuticals USD 16.64M 500K 2024-12
Amgen USD 1.91B 239M 2024-12
AstraZeneca 22.46B 781M 2024-12
Bayer EUR 7.52B 957M 2024-12
BioMarin Pharmaceutical 715.66M 458.25M 2024-09
Bristol-Myers Squibb USD 3.6B 133M 2024-12
Cytokinetics USD 20.37M 8.79M 2024-12
Eisai JPY 64.53B 1.79B 2024-12
Eli Lilly USD 3.23B 342.1M 2024-12
Exelixis USD 38.19M 21.12M 2025-01
Glaxosmithkline 13.47B 1.15B 2024-09
Incyte USD 197.46M 18.76M 2024-12
Ionis Pharmaceuticals USD 42.96M 33.91M 2024-12
MacroGenics USD 6.61M 1.38M 2024-09
Merck USD 4.08B 493M 2024-12
Moderna USD 405M 32M 2024-12
Neurocrine Biosciences 110M 282.7M 2024-12
Novartis USD 4.57B 485M 2024-12
Pfizer USD 5.63B 319M 2024-12
Sanofi 7.43B 105M 2024-06
Takeda JPY 460.18B 46.85B 2024-12
Ultragenyx Pharmaceutical USD 38.76M 2.77M 2024-12
Xencor USD 16.76M 2.01M 2024-12



Exelixis Leverandørgæld - Aktuelle værdier, historiske data, prognoser, statistik, diagrammer og økonomisk kalender - Mar 2025.